Anaesthesia and Intensive Care Medicine, published by Elsevier, is a vital resource in the fields of anesthesiology and critical care, devoted to disseminating innovative research and advancements spanning from 2003 to 2024. With an ISSN of 1472-0299 and an E-ISSN of 1878-7584, this journal provides a platform for healthcare professionals, researchers, and students to engage with a diversity of topics, including pain management, anesthesia techniques, and intensive care protocols. Although it currently holds a category quartile ranking of Q4 in 2023 within both Anesthesiology and Critical Care disciplines, the journal continuously aims to enhance its impact and relevance in the academic community. The journal does not operate on an open-access model, ensuring that subscribers and institutions have exclusive access to high-quality, peer-reviewed research. With its focus on advancing clinical practices and fostering scientific dialogue, Anaesthesia and Intensive Care Medicine is essential for those looking to stay at the forefront of patient care and medical research.

Aerospace Medicine and Human Performance is an influential journal published by the Aerospace Medical Association, serving as a vital resource for researchers and professionals dedicated to the study of human performance within the realms of aerospace environments. With an ISSN of 2375-6314 and an E-ISSN of 2375-6322, this journal has garnered attention since its inception in 2015 and is dedicated to the dissemination of innovative research, reviews, and case studies that address the complexities of human factors in aviation and space travel. Despite being classified in the Q4 quartile in both Medicine (Miscellaneous) and Public Health, Environmental and Occupational Health categories as of 2023, and its respective Scopus rankings showing opportunities for growth, the journal plays a critical role in bridging gaps in knowledge and promoting advancements in medical practices and safety standards in aerospace contexts. The journal operates under an Open Access model, ensuring that valuable research is readily available to a diverse audience. As it converges into the years up to 2024, it remains committed to enhancing the collaboration and communication within the aerospace medical community.

The Israel Journal of Veterinary Medicine, published by the Israel Veterinary Medical Association, serves as a vital resource for researchers, professionals, and students in the fields of veterinary medicine and animal science. With a commitment to advancing knowledge across diverse veterinary disciplines, this journal plays a crucial role in disseminating significant findings and innovations that influence both local and global veterinary practices. Although it currently holds a Q4 ranking in both the Animal Science and Zoology and Veterinary (miscellaneous) categories, the journal's open access policy, enabling free availability of articles, aspires to increase its accessibility and engagement among the academic community. The journal's convergence of research from 2007 to 2024 showcases its dedication to continuously contributing to the evolving landscape of veterinary science.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

RADIOPROTECTION, published by EDP SCIENCES S A, stands as a pivotal journal in the multidisciplinary fields of Nuclear Energy, Public Health, and Environmental Safety. With an ISSN of 0033-8451 and an E-ISSN of 1769-700X, this journal delves into the crucial aspects of radiation protection and its interactions with health and environment, providing a platform for researchers and professionals to disseminate their findings and insights. Despite being classified in the Q4 quartile for Health, Toxicology and Mutagenesis in 2023, its Q3 status in prestigious categories such as Nuclear Energy and Engineering, and Public Health, underscores its relevance in contemporary academic discourse. The journal continues to expand its cachet with converged years of publication from 1977 to 1981 and 1988 to 2024, ensuring a rich history of scholarly contributions. Access options for interested readers include traditional subscriptions, allowing for comprehensive engagement with a broad range of topics surrounding safety, sustainability, and risk management. Whether you are a researcher, professional, or student, RADIOPROTECTION serves as an essential resource for expanding understanding and fostering innovation within its field.

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, published by IOS Press, serves as an essential platform for advancing the understanding of risk and safety within the medical domain. With an ISSN of 0924-6479 and E-ISSN of 1878-6847, this journal has been dedicated to fostering critical discourse since its inception in 1990, reflecting a continuous commitment to the field through 2024. Positioned within the Q4 category in Health Policy and Q3 in Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, the journal provides valuable insights, empirical research, and theoretical analyses that speak to the diverse challenges faced in medical safety and risk management. Although it operates under a subscription model, the journal remains a vital resource for researchers, healthcare professionals, and students alike, facilitating the exchange of innovative ideas and best practices in health risk assessment. With Scopus ranks indicating its role as a key contributor in its categories, the INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE continues to shape the landscape of medical safety and policy discussions around the globe.

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

Journal of the South African Veterinary Association is a prominent Open Access journal dedicated to advancing the field of veterinary science since its inception in 1945. Published by MEDPHARM PUBLICATIONS PTY LTD, this journal stands out with an impactful HIndex and a commendable categorization in 2023, ranking Q3 in Medicine (miscellaneous) and Q2 in Veterinary (miscellaneous). With a Scopus rank of 96 out of 194 in the veterinary field, it serves as an essential resource for researchers, veterinary professionals, and students, promoting the dissemination of high-quality research and knowledge. The journal offers a platform for peer-reviewed articles covering diverse topics relevant to veterinary and animal health issues, encouraging expansive dialogue and collaboration within the academic community. Based in Centurion, South Africa, and accessible globally since it adopted an Open Access model in 1997, the journal exemplifies a commitment to accessibility and the sharing of knowledge.

Flugmedizin Tropenmedizin Reisemedizin is a prominent journal published by GEORG THIEME VERLAG KG, specializing in the interdisciplinary fields of aviation medicine, tropical medicine, and travel health. With its ISSN 1864-4538 and E-ISSN 1864-175X, this journal serves as a vital resource for healthcare professionals, researchers, and students who are dedicated to enhancing health and safety in the areas influenced by air travel and tropical environments. Although not currently open access, it boasts a rich repository of studies and reviews that address the latest findings and practices in these critical fields. The journal’s commitment to advancing knowledge and clinical practices makes it an essential read for those involved in travel medicine and public health initiatives, fostering an informed community of practitioners ready to tackle emerging global health challenges.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.